Regulatory Oversight
Unauthorized Fees
Elder Exploitation
The Victim Picture and Profile
Lawrence Jay Weiner
Lawrence Jay Weiner — An 80-year-old Parkinson’s and stage 4 cancer patient whose documented cognitive decline made him a vulnerable senior under FINRA Rule 2165.”
PUBLIC WARNING
If you or a loved one invests with Oppenheimer & Co., read this.
What happened to 80-year-old Lawrence Jay Weiner a terminal cancer and Parkinson’s patient—could happen to you.
When his family sought correction for unauthorized 56% fee increases:
- Oppenheimer escalated the harm instead of fixing it.
- FINRA ignored documented evidence.
- The system protected the firm, not the victim.
Oppenheimer Exploited a Dying, Cognitively Impaired 80-Year-Old Client
Oppenheimer & Co. and wealth manager Jerald Hymen increased Lawrence Jay Weiner’s management fees by 56% — from 1.25% to 1.95% — when he was 80 years old, dying of two terminal medical conditions (Parkinson’s disease and stage 4 lung cancer), with medically documented significant cognitive decline at the time of the rate increase.
The fee increase was made effective January 1, 2021 retroactively charged BEFORE the cognitively impaired signature was obtained on January 12, 2021, eleven days later. The smoking gun is Oppenheimer’s own internal email: the April 18, 2024 email from Patrick Wade of Oppenheimer’s Complaint Department (OPCO 00002 & 00003) confirming the original fees were reversed and re-billed at the higher rate in both accounts documented retroactive fee increases of 56%. When the family presented this proof and sought correction, Oppenheimer refused to take any corrective action “not a penny” and escalated the harm instead of fixing it.
Proven OPCO Fiduciary Breach
THE SMOKING GUN
April 18, 2024 email from Patrick Wade, Oppenheimer’s Complaint Department, confirming 56% retroactive fee increases were applied before obtaining the client’s signature. This internal email (OPCO 00002 & 00003) proves:
- Patrick Wade email
- Retroactive fee proof
- Dates + amounts
- Contradictions (John McGuire statement)
The Evidence Was Proven. The Award Was Zero.
In FINRA arbitration, the family proved — with Oppenheimer's own documents — everything above, PLUS that the fees were retroactively increased PRIOR to the cognitively impaired signature. The Patrick Wade email was in the record. The expert medical evidence was in the record.
The arbitration record also documents:
Written proof of arbitrator bias from Oppenheimer's own counsel: attorney John McGuire's April 21, 2025 email — “It is clear to me you have alienated the Chairman.”
Systematic discovery violations: Oppenheimer substituted useless activity log files for the specifically agreed-upon client financial spreadsheets, buried production in files far exceeding the agreed 30MB limit, and ignored the pre-hearing discovery agreements.
Motions to compel and for sanctions were filed and documented — and went unenforced. Arbitrator Ordower stated at the outset he would subpoena non-compliant discovery, then never did, forcing the hearing to proceed without the ordered financial evidence.
The arbitrator's own words: when asked whether opposing counsel was permitted to lie and present unlawful arguments, Arbitrator Ordower answered, “Yes, he can.”
Material misrepresentation by Oppenheimer's counsel: McGuire told the arbitrator the fee increase occurred in “mid-2022” when Oppenheimer's own Patrick Wade email proves it was January 1, 2021.
Coerced limitation of claims: at the April 28, 2025 pre-hearing conference, Jordan Weiner was dismissed as a claimant under threat of indefinite postponement, forcing abandonment of substantial valid claims.
Expert medical testimony from Dr. Ami Desai and Nicholas Gorsline — documenting significant cognitive decline at the time of the rate increase — was dismissed without analysis, and video evidence of the cognitive decline was excluded.
On May 23, 2025, Arbitrator Peter Ordower issued an award of ZERO relief, with no findings and no explanation — an award that disregarded Illinois fiduciary-duty and elder financial exploitation law (720 ILCS 5/16-1.3), SEC Regulation Best Interest, FINRA Rules 2010, 2165, 3110 and 4512, and even Oppenheimer's own professional Code of Conduct.
September 29, 2026
The federal court confirmed the arbitration award. The family will not appeal.
Read why →Oppenheimer's Silence on the Merits
Throughout this entire litigation, Oppenheimer has not addressed a single substantive ground for vacatur.
- Not the fraud. Attorney McGuire told the arbitrator the fee increase occurred in "mid-2022" when the Patrick Wade email proves it was January 1, 2021.
- Not the 56% fee increase. Imposed retroactively on an 80-year-old with Parkinson's disease and Stage 4 cancer, eleven days BEFORE obtaining any purported authorization.
- Not the arbitrator misconduct. Arbitrator Ordower dismissed expert medical testimony from Dr. Ami Desai and Nicholas Gorsline documenting over 400 therapy sessions proving "significant cognitive decline at the time of the rate increase."
- Not the arbitrator's own admission. When asked if opposing counsel was "permitted to lie," the arbitrator responded: "Yes, he can."
- Not the discovery violations. Oppenheimer deliberately substituted useless log files for requested financial spreadsheets and concealed evidence in voluminous production.
- Not the manifest disregard for elder protection laws. Including FINRA Rules 2165 and 3110, Illinois elder financial exploitation statutes, and SEC Regulation Best Interest.
The Case Overview
A Story of Betrayed Trust
This case exposes how Oppenheimer & Co. and wealth manager Jerald Hymen increased management fees by 56%—from 1.25% to 1.95%— during the final months of Lawrence Jay Weiner’s life. Mr. Weiner was 80 years old, suffering from Parkinson’s disease, stage 4 lung cancer, and medically documented cognitive decline. Despite this, Oppenheimer implemented the fee increase retroactively before obtaining his signature.
What This Case Reveals
- Retroactive fee increases implemented before written consent.
- Failure to protect a vulnerable senior client from financial exploitation.
- Multiple contradictory explanations from Oppenheimer personnel.
- FINRA’s refusal to act despite clear evidence of misconduct.
Why the Case Is Now in Federal Court
After FINRA Arbitration Case 24-02286 awarded zero relief despite overwhelming evidence, the family filed a Motion to Vacate Arbitration Award in the U.S. District Court for the Northern District of Illinois (Case No. 1:25-cv-09985).
The court filing seeks review on these grounds:
- Arbitrator ignored documented evidence of retroactive fee implementation.
- Elder financial exploitation and medical vulnerability were disregarded.
- Due process violations under the Federal Arbitration Act §10(a)(3).
This site makes the evidence available for independent review by regulators, journalists,
and other investors to promote transparency and accountability.
See the full documented evidence across six categories including fraud, cover-up, biased arbitration, expert testimony, standing, and federal court filings.
Those Impacted
Victims of Fiduciary Breach
Terri P. Tepper
83-year-old widow exposed to unauthorized fee increases and escalating harm while seeking corrective action.
View Profile
Jordan T. Weiner
Beneficiary who uncovered the fiduciary breach, documented evidence, and advanced the case to federal court.
View Profile
Lawrence Jay Weiner
An 80-year-old Parkinson's and stage 4 cancer patient whose condition made him a vulnerable senior under FINRA Rule 2165.
View ProfileCore Misconduct and Failures
FINRA Rule Breaches
SEC Regulation Violations
Illinois Law Violations
Code of Conduct
Fiduciary Duty Breach
Elder Client Exploitation
Timeline of Key Events
Fee Increase
Jan 1, 2021Oppenheimer imposed a 56% advisory fee hike, raising rates from 1.25% to 1.95%. The change was applied retroactively, taking effect before obtaining the client’s signed authorization.
Late Signature
Jan 12, 2021The client’s signature was collected 11 days after fees were already increased. This retroactive authorization demonstrates unauthorized account modification and a breach of fiduciary duty.
Complaints Ignored
2021–2022Multiple written and verbal complaints to Oppenheimer were dismissed. Instead of investigating, senior staff offered conflicting explanations, further concealing the unauthorized fee changes.
Award of Zero
May 23, 2025The FINRA award: “Claimants’ claims are denied in their entirety.” (Ex. 3)
Award Confirmed
Sept 29, 2026The federal court confirmed the arbitration award. The family will not appeal.
Documented Proof and Records
Internal Emails
Fee Analysis
Legal Filings
All evidence verified through court filings, attorney correspondence, and regulatory records.
Documented Violations
Proven OPCO Fiduciary Breach
Oppenheimer’s own internal records confirm the 56% fee increase was charged retroactively — effective January 1, 2021, eleven days before the cognitively impaired signature was obtained on January 12, 2021. The April 18, 2024 Patrick Wade email (OPCO 00002 & 00003) documents the reversal and re-billing of fees at the higher rate in both accounts
Learn More
Case No. 24-02286
FINRA Arbitration
The full record of the arbitration: the proven retroactive fee increase, the documented discovery violations, the coerced limitation of claims, the excluded medical evidence, Oppenheimer counsel’s own “you have alienated the Chairman” email — and the zero-relief award issued May 23, 2025 with no findings and no explanation.
View Case DetailsIndependent Review
FINRA Ombuds
The escalation record submitted to FINRA’s independent Ombuds office documenting the procedural failures in Case No. 24-02286, and the responses received.
Explore More
Regulatory Action
FINRA Department of Enforcement
The formal submissions to FINRA’s Department of Enforcement documenting the violations of FINRA Rules 2010, 2165, 3110 and 4512, together with the supporting evidence provided for regulatory review.
View Enforcement FilesCase No. 1:25-cv-09985
Federal Court Petition to Vacate
The petition asking the U.S. District Court for the Northern District of Illinois to vacate the FINRA award. On September 29, 2026, the court confirmed the award. The family will not appeal.
View Federal FilingsHave You Experienced Similar Issues?
If you believe you’ve been harmed by your financial advisor or experienced similar misconduct at Oppenheimer, we encourage you to reach out.